Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
.Inclusion Criteria:~1. Men and women between the ages of 18-65 who meet Diagnostic and Statistical Manual -IV criteria for current cocaine dependence~2. Used cocaine at least four days in the past month~3. Individuals must be in good general health~4. Individuals must be capable of giving informed consent and capable of complying with study procedures~5. Women of child-bearing age must agree to use a method of contraception with proven efficacy, consisting of one of the following: 1) Any form of hormonal contraception; 2) Intra-uterine device; 3) Sterilization; 4) Double-barrier contraception which is a combination of two of the following: condoms, spermicide, diaphragm. Pregnancy tests will be performed monthly and if a woman becomes pregnant, the study medication will be discontinued.~Exclusion Criteria:~1. Individuals who meet DSM-IV-TR criteria for bipolar disorder, schizophrenia, or any psychotic disorder other than transient psychosis due to drug abuse~2. Individuals with any other current Axis I psychiatric disorder as defined by DSM-IV-TR that in the investigator's judgment are unstable, or would be disrupted by study medication, or are likely to require pharmacotherapy during the study period~3. Individuals physiologically dependent on any other drugs (excluding nicotine or cannabis) which require medical intervention~4. Individuals with current psychostimulant abuse or dependence (other than cocaine dependence)~5. Individuals with current suicidal risk~6. Individuals with coronary vascular disease as indicated by history or suspected by abnormal ECG or history of cardiac symptoms~7. Unstable physical disorders which might make participation hazardous such as uncontrolled hypertension (SBP \> 140, diastolic blood pressure \> 90, or heart rate \> 100 when sitting quietly), acute hepatitis (patients with chronic mildly elevated transaminases (\< 3x upper limit of normal are acceptable), or uncontrolled diabetes~8. Individuals with a history of seizures, hyperthyroidism and/or glaucoma~9. History of allergic reaction to study medication~10. Women who are pregnant or nursing~11. Currently being prescribed psychotropic medication by another physician (other than sleep medication)~12. Individuals who are legally mandated (e.g., to avoid incarceration) to participate in substance abuse treatment program

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- lisdexamfetamine (Type: OTHER): open label

Based on this trial design, predict the completion outcome and termination type (if applicable).